FEMY · ISSUER CIK 1339005
FEMASYS INC
Between Jul 31, 2026 and Oct 28, 2026, 5 FEMASYS INC insiders reported $134K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Elefant Dov (Chief Financial Officer), with $50K.
↗5 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$134KInsider buying
$0.00Insider selling
+$134KNet open-market
Aug 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 202620:54 | Aug 7, 2026 | FEMY | Chief Clinical-Medical Affairs | P · Buy | $3.20 | +3,125 | 3,125 | New | +$10K | -63.5% | -55.9% |
| Aug 11, 202620:44 | Aug 7, 2026 | FEMY | Chief Technology Officer | P · Buy | $3.20 | +3,125 | 3,125 | New | +$10K | -63.5% | -55.9% |
| Aug 11, 202620:40 | Aug 7, 2026 | FEMY | Chief Operating Officer | P · Buy | $3.20 | +4,375 | 4,375 | New | +$14K | -63.5% | -55.9% |
| Aug 11, 202620:37 | Aug 7, 2026 | FEMY | Chief Financial Officer | P · Buy | $3.20 | +15,625 | 15,625 | New | +$50K | -63.5% | -55.9% |
| Aug 11, 202620:30 | Aug 7, 2026 | FEMY | Chief Executive Officer, Director | P · Buy | $3.20 | +15,625 | 15,625 | New | +$50K | -63.5% | -55.9% |